Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $493 - $629
4 Added 0.09%
4,398 $687,000
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $28,007 - $32,453
230 Added 5.52%
4,394 $539,000
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $324,663 - $371,471
2,555 Added 158.79%
4,164 $554,000
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $1.24 Million - $1.57 Million
-9,570 Reduced 85.61%
1,609 $220,000
Q4 2021

Feb 15, 2022

BUY
$140.36 - $173.01 $1.35 Million - $1.66 Million
9,601 Added 608.43%
11,179 $1.93 Million
Q3 2021

Nov 15, 2021

SELL
$132.95 - $158.0 $31,907 - $37,920
-240 Reduced 13.2%
1,578 $229,000
Q2 2021

Aug 16, 2021

SELL
$126.66 - $141.48 $27,105 - $30,276
-214 Reduced 10.53%
1,818 $240,000
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $13,755 - $16,000
-120 Reduced 5.58%
2,032 $261,000
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $30,090 - $34,189
267 Added 14.16%
2,152 $256,000
Q3 2020

Nov 13, 2020

SELL
$107.05 - $130.01 $118,397 - $143,791
-1,106 Reduced 36.98%
1,885 $216,000
Q2 2020

Aug 13, 2020

SELL
$73.34 - $122.61 $48,331 - $80,799
-659 Reduced 18.05%
2,991 $341,000
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $501,559 - $772,164
-6,675 Reduced 64.65%
3,650 $293,000
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $49,543 - $53,347
494 Added 5.02%
10,325 $1.1 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $644,537 - $707,575
6,587 Added 203.05%
9,831 $1.05 Million
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $3,577 - $4,281
-42 Reduced 1.28%
3,244 $330,000
Q1 2019

May 20, 2019

BUY
$80.68 - $89.92 $2,501 - $2,787
31 Added 0.95%
3,286 $295,000
Q4 2018

Feb 13, 2019

BUY
$79.75 - $108.38 $259,586 - $352,776
3,255 New
3,255 $271,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.